by Pamela Dahlen | Jan 3, 2022 | Community, News, Pilots
Acarbose is a commonly prescribed antidiabetic drug that helps control blood sugar levels by inhibiting human enzymes that break down complex carbohydrates. Now, new research from the laboratory of Princeton researcher Mohamed Donia demonstrates that some bacteria in...
by Pamela Dahlen | Aug 5, 2021 | Community, News, Pilots
A method that enables the storage and transport of vaccines and life-saving drugs at room temperature, eliminating the need for expensive refrigeration or freezing, is one of 12 technologies selected for development through the Philadelphia-based University City...
by Pamela Dahlen | Mar 2, 2021 | Community, News, Pilots
One of the major objectives of the NIH-funded New Jersey Alliance for Clinical and Translational Science (NJ ACTS) is to successfully translate biomedical discoveries to clinical applications by promoting creative and innovative science, and by providing pilot support...
by Pamela Dahlen | Nov 2, 2020 | Community, News, Pilots
The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) Community Engagement Core is excited to announce the selection of 2 Partnership and Innovation Accelerator Pilot Grant Program (PIAP) and 3 Advancing Health Equity and Social Justice (AHESJ)...
by Pamela Dahlen | Aug 31, 2020 | Community, News, Pilots
The purpose of the Partnership and Innovation Accelerator Pilot (PIAP) Program is to facilitate collaborations between academic researchers (Rutgers University, Princeton University, and/or New Jersey Institute of Technology) and community organizations so they can...
